Zealand Pharma A/S IPO Research Information

Zealand Pharma A/S IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Zealand Pharma A/S, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Zealand Pharma A/S	ZEAL - NASDAQ	$19.30-$19.30	$17.87	$18.12	4.375 million ADS	8/9/2017
Underwriter(s): Morgan Stanley, Goldman Sachs & Co.
Co-Manager(s): Guggenheim Securities, Needham & Co.
Industry: Health Care
Filing(s): Filed 2017-07-06 Terms Added 2017-08-01

Zealand Pharma A/S Quote & Chart - Click for current quote - ZEAL

About Zealand Pharma A/S (adapted from Zealand Pharma A/S prospectus):
They are a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. Currently, their shares are traded on Nasdaq Copenhagen A/S, or Nasdaq Copenhagen, under the symbol ZEAL. The closing price of our shares on Nasdaq Copenhagen on August 1, 2017 was DKK 121.50 per share, which equals a price of $19.30 per ADS based on the DKK/U.S. dollar exchange rate as of August 1, 2017.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ZEAL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.